Cargando…

Efficiently cleaved HIV-1 envelopes: can they be important for vaccine immunogen development?

The enormous diversity of HIV-1 is a significant impediment in selecting envelopes (Envs) that can be suitable for designing vaccine immunogens. While tremendous progress has been made in developing soluble, trimeric, native-like Env proteins, those that have elicited neutralizing antibodies (Abs) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Supratik, Kumar, Rajesh, Ahmed, Shubbir, Parray, Hilal Ahmad, Samal, Sweety
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549152/ https://www.ncbi.nlm.nih.gov/pubmed/33103053 http://dx.doi.org/10.1177/2515135520957763

Ejemplares similares

Method to identify efficiently cleaved, membrane-bound, functional HIV-1 (Human Immunodeficiency Virus-1) envelopes
por: Samal, Sweety, et al.
Publicado: (2019)

Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection
por: Kumar, Rajesh, et al.
Publicado: (2020)

Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
por: Parray, Hilal Ahmed, et al.
Publicado: (2020)

Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach
por: Khatri, Ritika, et al.
Publicado: (2022)

An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies
por: Boliar, Saikat, et al.
Publicado: (2015)

Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
por: Parray, Hilal Ahmad, et al.
Publicado: (2020)

Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein
por: Ahmed, Shubbir, et al.
Publicado: (2017)

Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes
por: Das, Supratik, et al.
Publicado: (2016)

Biophysical and Biochemical Characterization of the Receptor Binding Domain of SARS-CoV-2 Variants
por: Khatri, Ritika, et al.
Publicado: (2022)

Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo
por: Yadav, Naveen, et al.
Publicado: (2021)

Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
por: Parray, Hilal Ahmad, et al.
Publicado: (2021)

Correction: Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo
por: Samal, Sweety, et al.
Publicado: (2021)

The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
por: Perween, Reshma, et al.
Publicado: (2021)

Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail
por: Samal, Sweety, et al.
Publicado: (2018)

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
por: Murugavelu, Praveenkumar, et al.
Publicado: (2021)

Improving the immunogenicity of HIV-1 envelope trimer vaccines
por: Sanders, Rogier W
Publicado: (2011)

Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens
por: Sattentau, Quentin J.
Publicado: (2013)

Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
por: Derking, Ronald, et al.
Publicado: (2015)

Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
por: van Montfort, Thijs, et al.
Publicado: (2011)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Assessing immunogenicity barriers of the HIV-1 envelope trimer
por: Maliqi, Liridona, et al.
Publicado: (2023)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Asymmetric conformations of cleaved HIV-1 envelope glycoprotein trimers in styrene-maleic acid lipid nanoparticles
por: Wang, Kunyu, et al.
Publicado: (2023)

Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies
por: Chung, Nancy PY, et al.
Publicado: (2014)

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
por: Khatri, Ritika, et al.
Publicado: (2022)

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors
por: Prabakaran, Ponraj, et al.
Publicado: (2007)

Display of the HIV envelope protein at the yeast cell surface for immunogen development
por: Mathew, Elizabeth, et al.
Publicado: (2018)

Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
por: Torrents de la Peña, Alba, et al.
Publicado: (2017)

Characterization and Immunogenicity of HIV Envelope gp140 Zera(®) Tagged Antigens
por: Ximba, Phindile, et al.
Publicado: (2020)

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens
por: Margolin, Emmanuel, et al.
Publicado: (2019)

Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens
por: Ahmed, Shamim, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro
por: Vishwakarma, Preeti, et al.
Publicado: (2021)

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo
por: Raj, Sneha, et al.
Publicado: (2023)

Enhanced Immunogenicity of HIV-1 Envelope gp140 Proteins Fused to APRIL
por: Isik, Gözde, et al.
Publicado: (2014)

Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence
por: Nadai, Yuka, et al.
Publicado: (2019)

Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines
por: Endalew, Abaineh D., et al.
Publicado: (2019)

An Efficient Catalytic DNA that Cleaves L-RNA
por: Tram, Kha, et al.
Publicado: (2015)

Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein
Publicado: (1993)

A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein
por: Du, Sean X., et al.
Publicado: (2011)

Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies
por: Smith, Douglas H., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_baui3hk3rao1lir68vjnkbep9p